The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
A double-blind, randomized trial of topiramate in Lennox–Gastaut syndrome
Abstract
OBJECTIVE: To evaluate the efficacy and safety of topiramate as adjunctive therapy for Lennox-Gastaut syndrome in a multicenter, double-blind, placebo-controlled trial. BACKGROUND: Conventional antiepileptic drugs are frequently ineffective against multiple-seizure types of Lennox-Gastaut syndrome. METHODS: Ninety-eight patients >1 year to <30 years of age, with slow spike-and-wave patterns on EEG, seizure types including drop attacks, and either a history of or active atypical absence seizures, were assigned to an 11-week, double-blind treatment phase with either topiramate or placebo. Topiramate was titrated to target doses of approximately 6 mg/kg/d. RESULTS: For drop attacks, the most severe seizures associated with this syndrome, the median percentage reduction from baseline in average monthly seizure rate was 14.8% for the topiramate group and -5.1% (an increase) for the placebo group (p = 0.041). Topiramate-treated patients demonstrated greater improvement in seizure severity than did placebo-treated patients based on parental global evaluations (p = 0.037). The percentage of patients with a > or = 50% reduction from baseline in major seizures (drop attacks and tonic-clonic seizures) was greater in the topiramate group (15/46 or 33%) than in the control group (4/50 or 8%; p = 0.002). The most common adverse events in both groups were CNS related; there were no discontinuations from topiramate therapy due to adverse events. CONCLUSIONS: Topiramate adjunctive therapy was effective in reducing the number of drop attacks and major motor seizures and in improving seizure severity as determined by parental global evaluation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rank transformations as a bridge between parametric and nonparametric statistics
Conover, W. J., & Iman, R. L. (1981) · The American Statistician · doi:10.1080/00031305.1981.10479327 · Cited by 3,922
Statistical Methods for Rates and Proportions, 2nd ed
GROVE, W. A. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.12.1644-a · Cited by 3,748
Nonparametrics: Statistical Methods Based on Ranks
Mergenthaler, M. J., & Lehmann, E. L. (1979) · Technometrics · doi:10.2307/1268531 · Cited by 3,329
Efficacy of Felbamate in Childhood Epileptic Encephalopathy (Lennox-Gastaut Syndrome)
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280105 · Cited by 407
Lamotrigine for Generalized Seizures Associated with the Lennox–Gastaut Syndrome
Motte, J., Trevathan, E., Arvidsson, J. F. V., Barrera, M. N., Mullens, E. L., & Manasco, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712183372504 · Cited by 359
White, H. S., Brown, S. D., Woodhead, J. H., Skeen, G. A., & Wolf, H. H. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00045-4 · Cited by 356
Privitera, M., Fincham, R., Penry, J., Reife, R., Kramer, L., Pledger, G., & Karim, R. (1996) · Neurology · doi:10.1212/wnl.46.6.1678 · Cited by 339
Self-citationFaught, E., Wilder, B. J., Ramsay, R. E., Reife, R. A., Kramer, L. D., Pledger, G. W., & Karim, R. M. (1996) · Neurology · doi:10.1212/wnl.46.6.1684 · Cited by 289
Self-citationBen‐Menachem, E., Henriksen, O., Dam, M., Mikkelsen, M., Schmidt, D., Reid, S., Reife, R., Kramer, L., Pledger, G., & Karim, R. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00606.x · Cited by 243
Self-citationTassinari, C. A., Michelucci, R., Chauvel, P., Chodkiewicz, J., Shorvon, S., Henriksen, O., Dam, M., Reife, R., Pledger, G., & Karim, R. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00649.x · Cited by 190
Self-citationTopiramate: a review of preclinical, pharmacokinetic, and clinical data
Rosenfeld, W. E. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80006-9 · Cited by 185
Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy
Sharief, M., Viteri, C., Ben-Menachem, E., Weber, M., Reife, R., Pledger, G., & Karim, R. (1996) · Epilepsy Research · doi:10.1016/s0920-1211(96)00029-0 · Cited by 167
Self-citationBourgeois, B. F. D. (1998) · Archives of Neurology · doi:10.1001/archneur.55.9.1181 · Cited by 57
An Analytic Study of Epileptic Falls
Ikeno, T., Shigematsu, H., Miyakoshi, M., Ohba, A., Yagi, K., & Seino, M. (1985) · Epilepsia · doi:10.1111/j.1528-1157.1985.tb05701.x · Cited by 57
Testing the Hypothesis that Matters for Multiple Primary Endpoints
Capizzi, T. P., & Zhang, J. (1996) · Drug Information Journal · doi:10.1177/009286159603000410 · Cited by 34
Cited by
Guerrini, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68182-8 · Cited by 848
French, J. A., Kanner, A. M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C. L., Theodore, W. H., Bazil, C., Stern, J., Schachter, S. C., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000123693.82339.fc · Cited by 654
Self-citationChiron, C., Marchand, M., Tran, A., Rey, E., d'Athis, P., Vincent, J., Dulac, O., & Pons, G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03157-3 · Cited by 568
Arzimanoglou, A., French, J., Blume, W. T., Cross, J. H., Ernst, J.-P., Feucht, M., Genton, P., Guerrini, R., Kluger, G., Pellock, J. M., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70292-8 · Cited by 491
French, J. A., Kanner, A. M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C. L., Theodore, W. H., Bazil, C., Stern, J., Schachter, S. C., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000123695.22623.32 · Cited by 407
Self-citation
Metadata
- Authors
- Sachdeo, R. C., Glauser, T. A., Ritter, F., Reife, R., Lim, P., Pledger, G., & the Topiramate YL Study Group
- Venue
- Neurology
- Published
- 1999-06
- Volume
- 52
- Issue
- 9
- Pages
- 1882-1882
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2093392404
- Cited by
- 380
- References
- 16
- FWCI
- 17.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.